AzTrials
AzTrials

Post-traumatic Stress DisorderNCT06277973

Feasibility Study of the Self-Care Immediate Stabilization Procedure (ISP) ® After a Traumatic Experience

A study testing Eye Movement Desensitization and Reprocessing (EMDR) in people with Post-traumatic Stress Disorder and Acute Stress Disorder, run by Tel Aviv University at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to assess the feasibility of an online intervention platform based on the Immediate Stabilization Procedure (ISP®). This intervention targets early trauma reactions, aiming to reduce the risk of future PTSD. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Eye Movement Desensitization and Reprocessing (EMDR)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteIsrael
Study dates
Apr 2024to May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Hebrew speakers
  • Age 18 years or older
  • Have been in Israel since October 7th 2023 (the start of the war)
  • Were exposed to traumatic events during the war (Alarms, participated in battles, were attacked by terrorists, etcetera)
  • Access to PC/smartphone
  • Basic technological skills, ability to use the internet and email.

Who cannot join

  • Diagnosed with psychotic conditions.
  • Diagnosed with PTSD or complex PTSD.
  • Diagnosed with alcohol use disorder or drug abuse disorder.
  • Suicidal ideation
  • Treated with medication, psychotherapy, or any other mental treatment
  • About 10 randomly selected subjects will perform the intervention while recorded via zoom in the presence of a research assistant. This will allow us to assess the way subjects utilize this intervention.

Trial locations and contacts

1 site in 1 country.

Oren Asman, LLD contact

0097236408488

asman@tauex.tau.ac.il

Israel1 site

  • Tel Aviv University

    Tel Aviv

Other trials in Israel

About this study

Official title: Self-Care Immediate Stabilization Procedure (ISP) ® After a Traumatic Experience - A Feasibility Study

The study aims to assess the feasibility of an online intervention platform based on the Immediate Stabilization Procedure (ISP®). This intervention targets early trauma reactions, aiming to reduce the risk of future PTSD.

Read the detailed description

The primary objective of this study is to assess the effectiveness and feasibility of an immediate stabilization procedure adapted for online self-usage.

This procedure relies on the Eye Movement Desensitization and Reprocessing (EMDR) treatment, a well-known approach for post-traumatic responses. It involves bilateral stimulation of the brain's hemispheres through tapping on the body (i.e., the 'Butterfly Hug') and positive therapist statements during the tapping process. Key advantages of this protocol include: 1) prevents long-term post-traumatic symptoms; 2) short intervention - takes 5-20 minutes on average; 3) simple procedure that does not require recalling traumatic memories; 4) could be administered by non-mental health experts.

The ISP® protocol was found effective and safe in Israel (face-to-face) and the Ukraine (remote). In addition, online variations of the protocol for self-usage have been utilized globally. The on-going state of war emphasizes the critical need for immediate emotional support. A collaborative group involving researchers, mental health clinicians, and software engineers adapted the ISP® protocol for online self-usage. The current study aims to evaluate the efficiency of this intervention.

Being tested
Eye Movement Desensitization and Reprocessing (EMDR)
Keywords
Post-traumatic stress disorder (PTSD), EMDR (Eye Movement Desensitization Reprocessing), Immediate Stabilization Procedure [IPS(R)], The 'Butterfly Hug', Acute Stress Disorder
Medical subject headings
Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Acute

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eye Movement Desensitization and Reprocessing (EMDR)Behavioural

    The intervention is based on EMDR therapy for PTSD treatment. Participants will answer demographic questions, choose a primary distress source and watch a therapist-guided video (male or female, based on participant choice) that will instruct them through the 'Butterfly Hug' method (tapping alternately on both sides of the body) while hearing positive statements from the therapists on the chosen distress source. Before and after each video participants will rate their distress level on a scale between 0 and 10 and they can view up to 8 videos per session. The system will monitor distress levels, and if it detects a sustained deterioration, it will end the intervention. At the end of the intervention, participants will be given information about possible reactions to it and how to deal with them, they will be encouraged to use the technique whenever necessary, and they will be informed of relevant support lines that they can contact if needed.

Study groups in NCT06277973
Study groupRoleWhat they receive
Immediate Stabilization ProcedureExperimentalParticipants in this arm will answer questionnaires and go through the intervention according to this schedule: Day 1 - questionnaires (T1) Day 4 - intervention Day 7 - questionnaires (T2) Day 97 - follow up questionnaires (T3)
Receives: Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)
Waiting listOtherParticipants in this arm will answer questionnaires and do the intervention according to this schedule: Day 1 - questionnaires (T0) Day 7 - questionnaires (T1) Day 11- intervention Day 14- questionnaires (T2) Day 104- follow up questionnaires (T3) Thus, unlike in the experimental arm, the intervention will be delayed by a week and participants will fill out questionnaires one additional time, a week before they begin the same protocol as the experimental arm.
Receives: Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PCL-5 (Posttraumatic Stress Disorder Checklist)

    The PCL-5 is a self-report 20-item questionnaire that conforms with the DSM-5 symptom criteria for PTSD. Each item is rated on a scale of 0-4 and reflects a symptom of PTSD and the total scores range from 0 to 80. The severity scores for DSM-5 symptom clusters can be obtained by adding the scores for the items within each cluster, i.e., cluster B (items 1-5), cluster C (items 6-7), cluster D (items 8-14), and cluster E (items 15-20).

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  2. GAD-7 (General Anxiety Disorder-7)

    A widely used self-report measure for assessing symptoms of generalized anxiety disorder is the Generalized Anxiety Disorder-7 (GAD-7). Moreover, it can also be used to measure anxiety in the general population. This questionnaire contains seven items, and the final questionnaire result is the sum of the items. The total score ranges from 0 to 21, with each item's scale ranging from 0 to 3.

    0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: Severe anxiety

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  3. SSASI (The Short Scale Anxiety Sensitivity Index)

    The Short Scale Anxiety Sensitivity Index (SSASI) is a shorter version of the Anxiety Sensitivity Index-3 (ASI-3).

    This 5-items scale measures an individual's fear of the negative consequences associated with anxiety symptoms (i.e. anxiety sensitivity). Each item's scale ranges from 0 (very little) to 4 (very much).

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  4. BSI 18 (Brief Symptom Inventory)

    The Brief Symptom Inventory-18 (BSI-18) is a self-report measure consisting of 18 items, designed to effectively assess general mental health. Each item represents a symptom, and respondents are asked to rate these symptoms on a five-point scale, based on how much they have been bothered by the symptom in the prior week. The BSI-18 measure has three dimensions: somatization, depression, and anxiety; each contains 6 items.

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  5. DES-II (Dissociative Experiences Scale)

    The DES-II is a self-administered 28-item questionnaire, designed to measure the frequency of dissociative experiences of individuals. Score in this questionnaire ranges from 0 to 100, with higher score indicating higher dissociative symptoms and severity. For each item, respondents indicate how often a particular experience occurred to them, from "never" (0% of the time) to "always" (100%).

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  6. DERS (Difficulties in Emotion Regulation Scale)

    The Difficulties in Emotion Regulation Scale - 16 item version (DERS-16) is a self-report measure that assesses individuals' typical levels of difficulties in emotion regulation. The total score ranges from 16 to 80, with higher scores indicating greater difficulty regulating emotions.

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  7. NSESSS (The National Stressful Events Survey Acute Stress Disorder Short Scale)

    The National Stressful Events Survey Acute Stress Disorder Short Scale (NSESSS) is a 7-item scale that assesses the severity of acute stress disorder symptoms after experiencing a highly stressful event or experience. Each item is rated on a 5-point scale, with 0 indicating 'Not at all' and 4 indicating ' Extremely'. Individuals are asked to rate the severity of his or her posttraumatic stress disorder during the past 7 days. The total score can range from 0 to 28, with higher scores indicating greater severity of acute stress disorder.

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  8. SASRQ (Stanford Acute Stress Reaction Questionnaire)

    The SASRQ is a 30-item self-report questionnaire that is designed to evaluate the severity of traumatic stress symptoms over the past four weeks. The total score in this measure ranges from 0 to 150, with higher scores indicating more severe traumatic stress symptoms.

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  9. Exposure to traumatic event during the current war

    This measure will be composed of 4 items that will require participants to indicate whether they have experienced a traumatic event during the current war. Participants will need to specify the type of traumatic event, its severity and whether they have begun a psychological/ psychiatric treatment during this time.

    In the first baseline session the questions will refer to exposure to traumatic events during the war (up to the present moment). In all subsequent sessions, exposure to traumatic events will refer to events that occurred since the latest session.

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

  10. PDEQ (Peritraumatic Dissociative Experiences Questionnaire)

    The PDEQ is a self-report questionnaire consisting of 10 items, designed to assess peritraumatic dissociation. Respondents are asked to rate on a 5-point Likert scale ranging from 1 (Not at all true) to 5 (Extremely true), based on how much each statement relates to their experience during the traumatic event. The PDEQ has well-established psychometric properties, with higher total scores indicating increased peritraumatic dissociation.

    Measured: Experimental group - day 1, waiting list group - days 1 and 7

  11. TIS (Tonic Immobility Scale)

    TIS is a commonly used questionnaire to assess tonic immobility during traumatic events. This self-report instrument is divided into two parts: Tonic Immobility (7 items) and Fear (3 items). Each item is rated on a 7-point Likert scale. The range of the total score is between 0 and 60, with higher scores indicating more tonic immobility and fear during the event.

    Measured: Experimental group - day 1, waiting list group - days 1 and 7

  12. PDI (The Peritraumatic Distress Inventory)

    The PDI questionnaire is used to measure distress at the time of injury and consists of 13 items, with responses given on a 4-point Likert scale. The total score can range from 0 to 52, with higher scores representing greater symptom burden.

    Measured: Experimental group - day 1, waiting list group - days 1 and 7

  13. Questionnaires to test user experience of the system

    This questionnaire will be composed of 7 items on a 7-point scale and is designed to evaluate the system's ease of use, the degree to which it is easy to learn it, and its overall user experience. Higher total scores will represent a more positive user experience from the system.

    Measured: Experimental group - day 7, waiting list group - day 14

  14. Questionnaire for examining the experience of the intervention

    This questionnaire will consist of 3 items on a 7-point scale and will be used to assess the participant's satisfaction with the intervention, the extent to which it is helpful, and the overall experience. Higher total scores will represent a more positive user experience from the system.

    Measured: Experimental group - day 7, waiting list group - day 14

  15. Qualitative interview

    Approximately 20 subjects from the original sample will participate in a qualitative interview that will last about 30 minutes. The questions of the interview will focus on the experience of the participant from the system and their thought on its content.

    Measured: Experimental group - day 97, waiting list group - day 104

  16. Questionnaire regarding receiving emotional treatment

    Participants will be asked whether they have received emotional treatment (psychological, counseling, etc.) or medication since entering the study.

    Measured: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2024
  2. Study startApr 2024 (estimated)
  3. Primary completionJan 2025 (estimated)
  4. Study completionMay 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly allocated to one of the following groups: the experiment group and the waiting list group. Each group will receive the intervention but in the waiting list group this will occur a week later: Experiment group: Day 1 - questionnaires (T1) Day 4 - intervention Day 7 - questionnaires (T2) Day 97 - follow up questionnaires (T3) Waiting list group: Day 1 - questionnaires (T0) Day 7 - questionnaires (T1) Day 11- intervention Day 14- questionnaires (T2) Day 104- follow up questionnaires (T3) The parallel element of this model lies in the first week of the study: the experiment group goes through 2 measurements with the intervention in the middle of the week, whereas the waiting list group goes through 2 measurements without the intervention.
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06277973
Sponsor's protocol ID
0007551-2
Status last verified
Mar 2024
First submitted
11 Feb 2024
Last updated
27 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The IPD will be available (upon request) to other researchers. potentially identifying information will be removed.

Publications

  • Beatty, S., Moore-Felton, M.S., Zaporozhets, O. et al. Effectiveness of Immediate Stabilization Procedure (ISP®) Associated with Wartime Events. Int J Adv Counselling (2023). https://doi.org/10.1007/s10447-023-09531-2

  • Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986 Dec;174(12):727-35. doi: 10.1097/00005053-198612000-00004.

    PubMed 3783140

  • Brunet A, Weiss DS, Metzler TJ, Best SR, Neylan TC, Rogers C, Fagan J, Marmar CR. The Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. Am J Psychiatry. 2001 Sep;158(9):1480-5. doi: 10.1176/appi.ajp.158.9.1480.

    PubMed 11532735

  • Cardena E, Koopman C, Classen C, Waelde LC, Spiegel D. Psychometric properties of the Stanford Acute Stress Reaction Questionnaire (SASRQ): a valid and reliable measure of acute stress. J Trauma Stress. 2000 Oct;13(4):719-34. doi: 10.1023/A:1007822603186.

    PubMed 11109242

  • Derogatis LR. BSI 18, Brief Symptom Inventory 18: Administration, scoring and Procedure Manual. Minneapolis, MN: NCS Pearson, Incorporated; 2001.

  • Fuse T, Forsyth JP, Marx B, Gallup GG, Weaver S. Factor structure of the Tonic Immobility Scale in female sexual assault survivors: an exploratory and Confirmatory Factor Analysis. J Anxiety Disord. 2007;21(3):265-83. doi: 10.1016/j.janxdis.2006.05.004. Epub 2006 Jul 18.

    PubMed 16854560

  • Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, 26(1), 41-54. https://doi.org/10.1023/B:JOBA.0000007455.08539.94

  • Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, Friedman MJ. National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress. 2013 Oct;26(5):537-47. doi: 10.1002/jts.21848.

    PubMed 24151000

  • Marmar, C. R., Weiss, D. S., & Metzler, T. J. (1997). The Peritraumatic Dissociative Experiences Questionnaire. In J. P. Wilson & T. M. Keane (Eds.), Assessing psychological trauma and PTSD (pp. 412-428). The Guilford Press.

  • Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.

    PubMed 16717171

  • Weathers, F. W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2013). The ptsd checklist for dsm-5 (pcl-5). Scale available from the National Center for PTSD at www. ptsd. va. gov, 10(4), 206

  • Zvolensky MJ, Garey L, Fergus TA, Gallagher MW, Viana AG, Shepherd JM, Mayorga NA, Kelley LP, Griggs JO, Schmidt NB. Refinement of anxiety sensitivity measurement: The Short Scale Anxiety Sensitivity Index (SSASI). Psychiatry Res. 2018 Nov;269:549-557. doi: 10.1016/j.psychres.2018.08.115. Epub 2018 Aug 29.

    PubMed 30199696

Questions about this trial

What is this clinical trial studying?

A study testing Eye Movement Desensitization and Reprocessing (EMDR) in people with Post-traumatic Stress Disorder and Acute Stress Disorder, run by Tel Aviv University at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Oren Asman, LLD (0097236408488, asman@tauex.tau.ac.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PCL-5 (Posttraumatic Stress Disorder Checklist) (time frame: Experimental group - days 1, 7 and 97. Waiting list group - days 1, 7, 14 and 107). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06277973, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2024.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in